Global 500

Rank
273
Previous: 272 Next: 274

GlaxoSmithKline

Global Pharmaceuticals Brands
A blister pack containing Lamictal anti-epileptic tablets, produced by GlaxoSmithKline Plc, sits on a pharmacy counter in this arranged photograph in London, U.K., on Thursday, Dec. 29, 2016. The rapid pace of innovation among drugmakers may continue to be overshadowed by broader investment themes, such as the switch away from defensive stocks into more cyclical industries, during 2017, according to Bloomberg Intelligence. Photographer: Chris Ratcliffe/Bloomberg via Getty ImagesChris Ratcliffe—Bloomberg via Getty Images
  • Previous Rank
    278
  • Revenues ($M)
    37642
  • Revenue Percent Change
    3
  • Profits ($M)
    1230.9
  • Profits Percent Change
    -90.4
  • Assets ($M)
    72985
  • Employees
    99300

Company Information

CEOEmma N. Walmsley
SectorHealth Care
IndustryPharmaceuticals
HQ LocationBrentford, Britain
Websitewww.gsk.com
Years on Global 500 List23
Employees99,300

Key Financials (Last Fiscal Year)

Revenues ($M)$37,642
Profits ($M)$1,230.9
Assets ($M)$72,985
Total Stockholder Equity ($M)$1,389

Profit Ratios

Profit as % of Revenues3.3%
Profits as % of Assets1.7%
Profits as % of Stockholder Equity88.7%